Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at NFLX's multiple
$6.7870.0% above market
0.94 ZNTL revenue / share×7.21x NFLX P/S=$6.78
Market $3.99Implied $6.78
NFLX · current priceP/S 7.21x
$78.25Latest market snapshot
Implied fair value · at ZNTL's multiple
$45.1042.4% below market
10.63 NFLX revenue / share×4.24x ZNTL P/S=$45.10
Market $78.25Implied $45.10